Loading...
Docoh

Procter & Gamble (PG)

P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide.

Company profile

Ticker
PG
Exchange
Website
CEO
David Taylor
Employees
Incorporated
Location
Fiscal year end
SEC CIK
Subsidiaries
1837, LLC • Agile Pursuits Franchising, Inc. • Agile Pursuits, Inc. • Braun (Shanghai) Co., Ltd. • Braun GmbH • Celtic Insurance Company, Inc. • Charlie Banana (USA), LLC • Detergent Products B.V. • Detergent Products Sarl • Detergenti S.A. ...
IRS number
310411980

PG stock data

Calendar

5 Aug 22
19 Aug 22
30 Jun 23
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Jun 22 Jun 21 Jun 20 Jun 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 7.21B 7.21B 7.21B 7.21B 7.21B 7.21B
Cash burn (monthly) 437.33M 256.17M (no burn) (no burn) (no burn) (no burn)
Cash used (since last report) 735.1M 430.58M n/a n/a n/a n/a
Cash remaining 6.48B 6.78B n/a n/a n/a n/a
Runway (months of cash) 14.8 26.5 n/a n/a n/a n/a

Beta Read what these cash burn values mean

My notes
No notes yet
My annotations
No annotations yet

Community content

Community notes
No notes yet
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
18 Aug 22 Shailesh Jejurikar Common Stock Sell Dispose S No No 148.87 18,981 2.83M 279.289
18 Aug 22 R. Alexandra Keith Common Stock Sell Dispose S Yes No 149.15 1,289 192.25K 7,841.145
18 Aug 22 R. Alexandra Keith Common Stock Sell Dispose S No No 148.9207 17,347 2.58M 35,213.065
17 Aug 22 R. Alexandra Keith Common Stock Sell Dispose S Yes No 149.3294 1,080 161.28K 9,130.145
17 Aug 22 R. Alexandra Keith Common Stock Sell Dispose S No No 149.3294 14,530 2.17M 52,560.065
17 Aug 22 Jon R Moeller Common Stock Sell Dispose S No No 149.3294 29,405 4.39M 201,223.78
17 Aug 22 Jon R Moeller Common Stock Sell Dispose S Yes No 149.3294 767 114.54K 35,377.778
17 Aug 22 Shailesh Jejurikar Common Stock Sell Dispose S No No 149.3294 12,426 1.86M 19,260.289
16 Aug 22 R. Alexandra Keith Common Stock Grant Acquire A Yes No 0 2,369 0 10,210.145
16 Aug 22 R. Alexandra Keith Common Stock Grant Acquire A No No 0 31,877 0 67,090.065
62.1% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 3100 3173 -2.3%
Opened positions 122 157 -22.3%
Closed positions 195 177 +10.2%
Increased positions 1389 1392 -0.2%
Reduced positions 1192 1233 -3.3%
13F shares Current Prev Q Change
Total value 247.23B 231.63B +6.7%
Total shares 1.48B 1.52B -2.1%
Total puts 10.86M 11.28M -3.7%
Total calls 11.99M 13.69M -12.4%
Total put/call ratio 0.9 0.8 +9.9%
Largest owners Shares Value Change
Vanguard 222.37M $31.98B +2.2%
BLK Blackrock 161.38M $23.21B +3.9%
STT State Street 103.95M $14.95B -1.5%
Geode Capital Management 45.65M $6.55B +3.7%
Wellington Management 41.4M $5.95B -12.1%
MS Morgan Stanley 40.34M $5.8B +27.2%
BAC Bank Of America 36.34M $5.23B +27.3%
NTRS Northern Trust 31.05M $4.47B +0.1%
FMR 25.1M $3.61B -15.2%
BK Bank Of New York Mellon 24.12M $3.47B +1.6%
Largest transactions Shares Bought/sold Change
LGEN Legal & General 0 -17.9M EXIT
Parametric Portfolio Associates 0 -9.42M EXIT
MS Morgan Stanley 40.34M +8.63M +27.2%
BAC Bank Of America 36.34M +7.8M +27.3%
BLK Blackrock 161.38M +6.08M +3.9%
Wellington Management 41.4M -5.7M -12.1%
Vanguard 222.37M +4.85M +2.2%
Arrowstreet Capital, Limited Partnership 4.95M +4.57M +1196.0%
FMR 25.1M -4.48M -15.2%
GQG Partners 5.68M -4.24M -42.7%

Financial report summary

?
Risks
  • MACROECONOMIC CONDITIONS AND RELATED FINANCIAL RISKS
  • Our business is subject to numerous risks as a result of having significant operations and sales in international markets, including foreign currency fluctuations, currency exchange or pricing controls and localized volatility.
  • Uncertain economic or social conditions may adversely impact demand for our products or cause our customers and other business partners to suffer financial hardship, which could adversely impact our business.
  • Disruptions in credit markets or to our banking partners or changes to our credit ratings may reduce our access to credit or overall liquidity.
  • Changing political conditions could adversely impact our business and financial results.
  • The war between Russia and Ukraine has adversely impacted and could continue to adversely impact our business and financial results.
  • Our business results depend on our ability to manage disruptions in our global supply chain.
  • Our businesses face cost fluctuations and pressures that could affect our business results.
  • The ability to achieve our business objectives depends on how well we can compete with our local and global competitors in new and existing markets and channels.
  • A significant change in customer relationships or in customer demand for our products could have a significant impact on our business.
  • If the reputation of the Company or one or more of our brands erodes significantly, it could have a material impact on our financial results.
  • We rely on third parties in many aspects of our business, which creates additional risk.
  • A significant information security or operational technology incident, including a cybersecurity breach, or the failure of one or more key information or operations technology systems, networks, hardware, processes and/or associated sites owned or operated by the Company or one of its service providers could have a material adverse impact on our business or reputation.
  • We must successfully manage the demand, supply and operational challenges associated with the effects of a disease outbreak, including epidemics, pandemics or similar widespread public health concerns.
  • BUSINESS STRATEGY & ORGANIZATIONAL RISKS
  • We must successfully manage ongoing acquisition, joint venture and divestiture activities.
  • Our business results depend on our ability to successfully manage productivity improvements and ongoing organizational change, including attracting and retaining key talent as part of our overall succession planning.
Management Discussion
  • The key metrics included in the discussion of our consolidated results of operations include net sales, gross margin, selling, general and administrative costs (SG&A), operating margin, other non-operating items, income taxes and net earnings. The primary factors driving year-over-year changes in net sales include overall market growth in the categories in which we compete, product initiatives, competitive activities (the level of initiatives, pricing and other activities by competitors), marketing spending, retail executions (both in-store and online) and acquisition and divestiture activity, all of which drive changes in our underlying unit volume, as well as our pricing actions (which can also impact volume), changes in product and

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: acumen, adapting, agility, algorithm, ambition, amidst, amplify, authentic, broader, Carbon, CDP, chip, claim, crucial, delighting, destruction, deviate, diaper, driver, escalate, EU, Farmacy, geopolitical, greenhouse, increasingly, irresistible, irresistibly, judgement, LGPD, Medicare, neighboring, neutral, notable, occurrence, oil, Organisation, Ouai, Overnight, palm, PIPL, port, proximity, Raman, reality, reimplementation, resilience, rest, resurgence, reusability, role, SASB, sexual, shortage, situation, SOFR, stronger, suggest, suspended, Task, TCFD, TULA, Ukraine, virgin, Whaley, wood, worsen
Removed: accelerate, added, Algeria, attractive, Bismol, competitor, continuously, credited, David, developed, dissolved, earlier, enrollment, entirety, existed, February, fragmented, initiative, intent, July, KGaA, long, marketable, Merck, minimal, October, OTC, outsourcing, parent, partnership, Pepto, permanently, PGT, Pharmaceutical, Recommending, recurring, reestablish, reestablished, reinforce, requiring, resulted, returned, reverse, sacrifice, Simplifying, step, streamlining, structurally, tangible, Taylor, Teva, trading, unconditionally, withdrawal